The importance of anemia and its correction in the management of severe congestive heart failure (Q28194293)

European Journal of Heart Failure

Europe PubMed Central

title

The importance of anemia and its correction in the management of severe congestive heart failure (English)

0 references

main subject

heart failure

0 references

congestive heart failure

1 reference

Donald S Silverberg

1

0 references

Dov Wexler

series ordinal

2

0 references

Adrian Iaina

series ordinal

3

0 references

language of work or name

English

0 references

publication date

December 2002

0 references

published in

0 references

volume

4

0 references

issue

6

0 references

page(s)

681-6

0 references

cites work

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Erythropoietin and transferrin metabolism in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

An overview of tumor necrosis factor alpha and the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Morbidity risk assessment in the surgically anemic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Acute precipitants of congestive heart failure exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

The pathological consequences of anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

What are the short-term and long-term consequences of anaemia in CRF patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Survival of patients with a new diagnosis of heart failure: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

Anemia, transfusion, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

Blood Transfusion in Elderly Patients with Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

Effect of erythropoietin on cardiovascular diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021

Intravenous ferric saccharate as an iron supplement in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900115-0

7 January 2021